Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26903071.
- Also identified by DOI 10.1158/1078-0432.CCR-15-3168.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The article by Curti and colleagues highlights the potential of natural killer (NK) cell-based adoptive cellular immunotherapy in oncology, currently boosted by advances in the knowledge on NK cell biology and in theirex vivoGMP manipulation. Several issues deserve attention to fully achieve the translation of these advances to the clinic.
Medical subject headings
- Immunotherapy
- Killer Cells, Natural
- Leukemia, Myeloid, Acute